Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

  • ESTA - Electronic System for Travel Authorization
Receive Latest News

Share Us

26th International Diabetes and Healthcare Conference

View: 106

Website | Edit Freely


Deadline: August 30, 2018 | Date: November 26, 2018-November 27, 2018

Venue/Country: Finland

Updated: 2018-07-04 15:24:50 (GMT+9)

Call For Papers - CFP

Diabetic 2018 welcomes you to grace with your presence in the 26th International Diabetes and Healthcare Conference (Diabetic 2018) to be held at Helsinki, Finland during November 26-27, 2018. This International Diabetes and healthcare conference will bring together diabetic researchers, diabetologists, cardiac surgeons, professors and scientists to discuss strategies for diabetes globally. Diabetic 2018 is designed to provide divergent and prevailing education that will gather medical professional’s familiar of the issues affecting the prevention, diagnosis and treatment of diabetes care. Undoubtedly the participant at this diabetic 2018 congress will be able to exchange with the best experts in the specialty and will return home with extensive knowledge.

Diabetic 2018 welcomes you at Diabetes and Healthcare conference going to be held in Helsinki, Finland during November 26-27, 2018 which unites brief keynote presentations, speaker talks, exhibitions, Symposiums, workshops. Diabetic 2018 is the Diabetic meetings which will be most visited by all the eminent diabetologists, diabetes educators, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. This Diabetic conference will assist to framework organization, B2B teaming up amidst specialists and academicians. Diabetes Conferences promotes awareness against risk factors and advancements about the diabetes. This diabetes meeting lay a platform for postgraduate education and scientific work in the fields of diabetes, cardiology, healthcare, hypertension, nutrition, oncology and stem cell research in diabetes and paediatric diabetes.

Conference Highlights:

Recent Advancement in Diabetes

Diabetes and Nutrition

Diabetes and Cancer

Genetic Diabetes

Diabetes and Immunology

Biomarkers for Diabetes

Cellular and Molecular Endocrinology

Case Studies and New Research Advances in Diabetes

Consequences of Diabetes in Human

Hypertension and Diabetes

Neurologic problems and Diabetes

Diabetes and Treatment

Diabetic Retinopathy

Stem Cell Therapy for Diabetes

Diabetes in Healthcare

Endocrine Complications of Diabetes

Diabetes and Cardiovascular Diseases

Pediatric diabetes

Recent advances in nanotechnology for diabetes

Why to attend?

This conference will provide the focused learning on the distribution of knowledge, opportunities to network and discuss science and medicine on diabetes and healthcare and the recent advances and technologies related Diabetes for the making of better health. Fresh minds will have the opportunity to explore more areas of expertise on Healthcare in Diabetes. With members from all around the world increasing the knowledge about Diabetes and Healthcare and the increase in the new advance related to Diabetes, this is your best chance to reach the largest gathering of participants from Diabetes Community.

Target Audiences:

• Diabetologists

• Researchers

• Endocrinologists

• Doctors

• Researchers

• Physicians

• Nutritionist

• Scientists

• Academic professionals

• Medical colleges and Pharma companies

• Medical hospitals

• Students

• Manufacture medical devices & companies

• Healthcare Training Institute

• Oncologists

• Neurologists

• Pediatric doctors

Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.